Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Lee’s Pharmaceutical Holdings Limited ( (HK:0950) ) has provided an update.
Lee’s Pharmaceutical Holdings Limited announced the grant of share options to subscribe for 1,764,000 ordinary shares under its Share Option Scheme. This move, effective from October 15, 2025, aims to incentivize eligible participants, with options exercisable in two phases starting from October 2026 and April 2027. The exercise price is set at HK$2.022 per share, reflecting the market conditions, and the total market value of the shares granted is approximately HK$3,492,720. This strategic decision is expected to enhance employee engagement and align their interests with the company’s long-term growth objectives.
The most recent analyst rating on (HK:0950) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on Lee’s Pharmaceutical Holdings Limited stock, see the HK:0950 Stock Forecast page.
More about Lee’s Pharmaceutical Holdings Limited
Lee’s Pharmaceutical Holdings Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on developing, manufacturing, and distributing pharmaceutical products, primarily targeting the Asian market.
Average Trading Volume: 6,392,564
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.18B
For an in-depth examination of 0950 stock, go to TipRanks’ Overview page.